What does PHARMACIE ESSER do?

PHARMACIE ESSER is a pharmacy in Plombières. Private Limited, started on 10 December 2010, 1 establishment.

What is the address of PHARMACIE ESSER?

The registered office of PHARMACIE ESSER is located at Place communale 28, 4850 Plombières.

Is PHARMACIE ESSER still active?

Yes. According to the CBE (31 October 2026) PHARMACIE ESSER is active, legal situation “Normale toestand”, started on 10 December 2010.

Is PHARMACIE ESSER registered on Peppol?

Yes, PHARMACIE ESSER is registered on the Peppol network with ID 0208:0831781235.

What is the enterprise number of PHARMACIE ESSER?

The enterprise number of PHARMACIE ESSER is BE0831781235.

When was PHARMACIE ESSER founded?

PHARMACIE ESSER was founded on 10 December 2010.

Who are the directors of PHARMACIE ESSER?

According to the 2025 annual accounts, the directors of PHARMACIE ESSER are: BENEDICTE ESSER.

Is PHARMACIE ESSER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 December 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE ESSER make in 2025?

PHARMACIE ESSER posted a profit after taxes of € 82,439 in financial year 2025.

What is the revenue of PHARMACIE ESSER?

As a small company, PHARMACIE ESSER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 461,375.

How much does an employee at PHARMACIE ESSER earn?

The average wage cost per full-time employee at PHARMACIE ESSER was € 67,800 in 2025: staff costs of € 203,327 for 3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE ESSER have?

According to the 2025 annual accounts, PHARMACIE ESSER has 3 full-time equivalents (FTE).

PHARMACIE ESSER (Private Limited) - Plombières

Dossier PHARMACIE ESSER, printed on 31 October 2026 from databakkes.be/en/0831781235/pharmacie-esser. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 29 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE ESSER from Plombières, company number BE0831781235, closed financial year 2025 with a result of € 82,439 after tax. For that financial year PHARMACIE ESSER recorded a gross margin of € 461,375 and equity of € 513,870. Compared with financial year 2024, the result moved from € 79,273 to € 82,439. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Healthy

€ 513,870

▼ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 82,439

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 56,805

▼ 26% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 202,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 203,327

▲ 1% vs 2024

€ 67,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 24,627

▲ 15% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 713,452

▼ 10% vs 2024

€ 102,059 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 52,005

▼ 24% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 57,554

▲ 54% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 362,786 Gross margin 2022: € 362,786 First fiscal year in the series	€ 409,672 Gross margin 2023: € 409,672 ▲ 13% vs 2022 (€ 362,786) Favourable step	€ 454,506 Gross margin 2024: € 454,506 ▲ 11% vs 2023 (€ 409,672) Favourable step	€ 461,375 Gross margin 2025: € 461,375 ▲ 2% vs 2024 (€ 454,506) Favourable step	▲ 2%
Profit after taxes	€ 54,316 Profit after taxes 2022: € 54,316 First fiscal year in the series	€ 80,047 Profit after taxes 2023: € 80,047 ▲ 47% vs 2022 (€ 54,316) Favourable step	€ 79,273 Profit after taxes 2024: € 79,273 ▼ 1% vs 2023 (€ 80,047) Unfavourable step	€ 82,439 Profit after taxes 2025: € 82,439 ▲ 4% vs 2024 (€ 79,273) Favourable step	▲ 4%
Equity	€ 565,403 Equity 2022: € 565,403 First fiscal year in the series	€ 645,450 Equity 2023: € 645,450 ▲ 14% vs 2022 (€ 565,403) Favourable step	€ 633,431 Equity 2024: € 633,431 ▼ 2% vs 2023 (€ 645,450) Unfavourable step	€ 513,870 Equity 2025: € 513,870 ▼ 19% vs 2024 (€ 633,431) Unfavourable step	▼ 19%
Total debts	€ 778,273 Total debts 2022: € 778,273 First fiscal year in the series	€ 831,093 Total debts 2023: € 831,093 ▲ 7% vs 2022 (€ 778,273) Unfavourable step	€ 1,101,512 Total debts 2024: € 1,101,512 ▲ 33% vs 2023 (€ 831,093) Unfavourable step	€ 1,144,326 Total debts 2025: € 1,144,326 ▲ 4% vs 2024 (€ 1,101,512) Unfavourable step	▲ 4%
Cash	€ 75,102 Cash 2022: € 75,102 First fiscal year in the series	€ 119,764 Cash 2023: € 119,764 ▲ 59% vs 2022 (€ 75,102) Favourable step	€ 76,402 Cash 2024: € 76,402 ▼ 36% vs 2023 (€ 119,764) Unfavourable step	€ 56,805 Cash 2025: € 56,805 ▼ 26% vs 2024 (€ 76,402) Unfavourable step	▼ 26%
Land & buildings	€ 588,441 Land & buildings 2022: € 588,441 First fiscal year in the series	€ 598,670 Land & buildings 2023: € 598,670 ▲ 2% vs 2022 (€ 588,441) Unchanged	€ 789,933 Land & buildings 2024: € 789,933 ▲ 32% vs 2023 (€ 598,670) Unchanged	€ 746,913 Land & buildings 2025: € 746,913 ▼ 5% vs 2024 (€ 789,933) Unchanged	▼ 5%
Retained profit	€ 543,403 Retained profit 2022: € 543,403 First fiscal year in the series	€ 623,450 Retained profit 2023: € 623,450 ▲ 15% vs 2022 (€ 543,403) Favourable step	€ 611,431 Retained profit 2024: € 611,431 ▼ 2% vs 2023 (€ 623,450) Unfavourable step	€ 491,870 Retained profit 2025: € 491,870 ▼ 20% vs 2024 (€ 611,431) Unfavourable step	▼ 20%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 91,292 Dividend 2024: € 91,292 Unchanged (€ 0) Unchanged	€ 202,000 Dividend 2025: € 202,000 ▲ 121% vs 2024 (€ 91,292) Unchanged	▲ 121%
Bank debt	€ 580,123 Bank debt 2022: € 580,123 First fiscal year in the series	€ 563,961 Bank debt 2023: € 563,961 ▼ 3% vs 2022 (€ 580,123) Favourable step	€ 796,293 Bank debt 2024: € 796,293 ▲ 41% vs 2023 (€ 563,961) Unfavourable step	€ 713,452 Bank debt 2025: € 713,452 ▼ 10% vs 2024 (€ 796,293) Favourable step	▼ 10%
Balance sheet total	€ 1,343,675 Balance sheet total 2022: € 1,343,675 First fiscal year in the series	€ 1,476,543 Balance sheet total 2023: € 1,476,543 ▲ 10% vs 2022 (€ 1,343,675) Unchanged	€ 1,734,943 Balance sheet total 2024: € 1,734,943 ▲ 18% vs 2023 (€ 1,476,543) Unchanged	€ 1,658,195 Balance sheet total 2025: € 1,658,195 ▼ 4% vs 2024 (€ 1,734,943) Unchanged	▼ 4%
Employees (FTE)	3.3 Employees (FTE) 2022: 3.3 First fiscal year in the series	3 Employees (FTE) 2023: 3 ▼ 0.3 vs 2022 (3.3) Unchanged	3 Employees (FTE) 2024: 3 Unchanged (3) Unchanged	3 Employees (FTE) 2025: 3 Unchanged (3) Unchanged

Key figures of PHARMACIE ESSER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE ESSER?

What happened at PHARMACIE ESSER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 82,439 (▲ 4% vs 2024). Source: NBB ↗
Jan 1, 2011 New establishment in Plombières. KBO
Dec 10, 2010 Start of the company according to the CBE. KBO
2010 BENEDICTE ESSER became a director. NBB

In short

From € 54,316 profit in 2022 to € 82,439 profit in 2025.

Paid € 119,819 in corporate taxes since 2022.

Best year ever: 2025, with € 82,439 profit.

On average € 153,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BENEDICTE ESSER

PHARMACIE ESSER

Behind PHARMACIE ESSER is BENEDICTE ESSER.

Directors

According to the 2025 annual accounts

BENEDICTE ESSER

Manager

since 2010

Establishments

Establishment units

Physical locations of this company

Registered office

Place communale 28

4850 Plombières

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0831.781.235

VAT number

BE 0831.781.235

Registered office

Place communale 28, 4850 Plombières

Names & denominations

PHARMACIE ESSER

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

10 December 2010

Peppol

Active · Active since 4 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Verhuur en lease van medisch en paramedisch materieel

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Vervaardiging van farmaceutische grondstoffen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE ESSER

Warning lights

Financials

What happened to PHARMACIE ESSER?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions